Literature DB >> 16722994

Difference in expression level and localization of DNA polymerase beta among human esophageal cancer focus, adjacent and corresponding normal tissues.

Z M Dong1, N G Zheng, J L Wu, S K Li, Y L Wang.   

Abstract

The aim of this paper was to study the expression level and localization of DNA polymerase beta (polbeta) and the difference in those among the human esophageal cancer focus, cancer adjacent and corresponding normal esophageal tissues. These three kinds of tissues were collected from surgically resected tissues in 17 patients with esophageal carcinoma in Linzhou, China. Each of a total of 51 tissue pieces was divided into two aliquots: one aliquot for detection of polbeta expression by in situ hybridization and by immunohistochemistry; another for detection of polbeta expression by RNA dot blot and immunoblotting. In the tissue specimens detected by in situ hybridization and immunohistochemistry, the cancer focus tissue had much stronger polbeta expression signals localized in the scattered heteromorphologic cancer cells. The cancer adjacent tissue exhibited slightly stronger polbeta signals mainly localized in the epithelial proliferating cells and the corresponding normal tissue displayed weak polbeta signals basically located in the epithelial basal cells. The difference in expression level of polbeta among the three kinds of tissues detected by RNA dot blot and immunoblotting was similar to the above results. Further, the truncated POLB could be demonstrated in both cancer focus and cancer adjacent tissues, but could not be found in the corresponding normal tissue in immunoblotting. The results suggest that the overexpression of polbeta with truncated form may be a potential biomarker for early diagnosis of human esophageal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16722994     DOI: 10.1111/j.1442-2050.2006.00560.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  11 in total

Review 1.  Targeting DNA polymerase ß for therapeutic intervention.

Authors:  Eva M Goellner; David Svilar; Karen H Almeida; Robert W Sobol
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

2.  DNA polymerase beta promoter mutations affect gene transcription, translation and the sensitivity of esophageal cancer cells to cisplatin treatment.

Authors:  Tao Wang; Wenqiao Zang; Yunyun Ma; Min Li; Xiaoyan Xuan; Na Wang; Rui Wu; Yuebai Li; Ziming Dong; Guoqiang Zhao
Journal:  Mol Biol Rep       Date:  2012-11-03       Impact factor: 2.316

Review 3.  Molecular alterations and clinical relevance in esophageal squamous cell carcinoma.

Authors:  Li Shang; Mingrong Wang
Journal:  Front Med       Date:  2013-09-03       Impact factor: 4.592

4.  DNA polymerase β mutations and survival of patients with esophageal squamous cell carcinoma in Linzhou City, China.

Authors:  Min Li; Wenqiao Zang; Yuanyuan Wang; Yunyun Ma; Xiaoyan Xuan; Jimin Zhao; Lulu Liu; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2014-01

5.  HAX-1 promotes the chemoresistance, invasion, and tumorigenicity of esophageal squamous carcinoma cells.

Authors:  Sa-jia Sun; Long Feng; Guo-qiang Zhao; Zi-ming Dong
Journal:  Dig Dis Sci       Date:  2012-03-27       Impact factor: 3.199

6.  Involvement of p38MAPK-ATF2 signaling pathway in alternariol induced DNA polymerase β expression.

Authors:  Jimin Zhao; Junfen Ma; Jing Lu; Yanan Jiang; Yanyan Zhang; Xiaoyan Zhang; Jun Zhao; Hongyan Yang; Youtian Huang; Mingyao Zhao; Kangdong Liu; Ziming Dong
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

7.  Gastrointestinal hyperplasia with altered expression of DNA polymerase beta.

Authors:  Katsuhiko Yoshizawa; Elena Jelezcova; Ashley R Brown; Julie F Foley; Abraham Nyska; Xiangli Cui; Lorne J Hofseth; Robert M Maronpot; Samuel H Wilson; Antonia R Sepulveda; Robert W Sobol
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

8.  Comparative assessment of plasmid and oligonucleotide DNA substrates in measurement of in vitro base excision repair activity.

Authors:  Esther W Hou; Rajendra Prasad; Kenjiro Asagoshi; Aya Masaoka; Samuel H Wilson
Journal:  Nucleic Acids Res       Date:  2007-08-24       Impact factor: 16.971

9.  Dysregulated Expression and Subcellular Localization of Base Excision Repair (BER) Pathway Enzymes in Gallbladder Cancer.

Authors:  Manoj Kumar; Vijay Kumar Shukla; Pravas Kumar Misra; Mercy Jacob Raman
Journal:  Int J Mol Cell Med       Date:  2018-08-18

10.  Non-muscle invasive bladder cancer tissues have increased base excision repair capacity.

Authors:  Berna Somuncu; Selcuk Keskin; Fatma Merve Antmen; Yesim Saglican; Aysegul Ekmekcioglu; Tugce Ertuzun; Mustafa Bilal Tuna; Can Obek; David M Wilson; Umit Ince; Ali Riza Kural; Meltem Muftuoglu
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.